Cymat Technologies Ltd.
CYMHF
$0.07
$0.00-5.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -36.58% | -27.87% | 121.42% | 76.68% | 33.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.58% | -27.87% | 121.42% | 76.68% | 33.99% |
| Cost of Revenue | -24.55% | -10.87% | 54.70% | 8.69% | -13.96% |
| Gross Profit | -106.28% | -276.29% | 223.89% | 263.76% | 160.05% |
| SG&A Expenses | -3.28% | -15.72% | -20.93% | -28.75% | -29.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.61% | -14.54% | 9.39% | -11.23% | -21.26% |
| Operating Income | -10.37% | 3.38% | 38.25% | 53.40% | 44.95% |
| Income Before Tax | -17.64% | -7.05% | 23.21% | 39.09% | 35.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.64% | -7.05% | 23.21% | 39.09% | 35.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.64% | -7.05% | 23.21% | 39.09% | 35.73% |
| EBIT | -10.37% | 3.38% | 38.25% | 53.40% | 44.95% |
| EBITDA | -18.36% | -2.82% | 40.49% | 57.62% | 48.93% |
| EPS Basic | -7.45% | -1.43% | 25.05% | 42.93% | 41.25% |
| Normalized Basic EPS | -8.51% | -2.28% | 23.72% | 38.79% | 37.50% |
| EPS Diluted | -7.45% | -1.43% | 25.05% | 42.93% | 41.25% |
| Normalized Diluted EPS | -8.51% | -2.28% | 23.72% | 38.79% | 37.50% |
| Average Basic Shares Outstanding | 11.15% | 5.09% | 2.43% | 6.22% | 9.09% |
| Average Diluted Shares Outstanding | 11.15% | 5.09% | 2.43% | 6.22% | 9.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |